These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975 [TBL] [Abstract][Full Text] [Related]
8. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state. Hodson L; Bickerton AS; McQuaid SE; Roberts R; Karpe F; Frayn KN; Fielding BA Diabetes; 2007 Oct; 56(10):2433-41. PubMed ID: 17601988 [TBL] [Abstract][Full Text] [Related]
9. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases. Nakajima K; Nakajima Y; Takeichi S; Fujita MQ Atherosclerosis; 2008 May; 198(1):237-46. PubMed ID: 17977545 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Thomsen C; Storm H; Holst JJ; Hermansen K Am J Clin Nutr; 2003 Mar; 77(3):605-11. PubMed ID: 12600850 [TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes. Ai M; Tanaka A; Ogita K; Sekinc M; Numano F; Numano F; Reaven GM J Am Coll Cardiol; 2001 Nov; 38(6):1628-32. PubMed ID: 11704373 [TBL] [Abstract][Full Text] [Related]
13. Beyond fasting plasma glucose: the association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults. Bhat SL; Abbasi FA; Blasey C; Reaven GM; Kim SH Metabolism; 2013 Sep; 62(9):1223-6. PubMed ID: 23809477 [TBL] [Abstract][Full Text] [Related]
14. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis. van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212 [TBL] [Abstract][Full Text] [Related]
15. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. Ai M; Tanaka A; Ogita K; Sekine M; Numano F; Numano F; Reaven GM J Clin Endocrinol Metab; 2000 Oct; 85(10):3557-60. PubMed ID: 11061501 [TBL] [Abstract][Full Text] [Related]
16. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus. Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. Twickler TB; Wilmink HW; Schreuder PC; Cabezas MC; van Dam PS; Koppeschaar HP; Erkelens DW; Dallinga-Thie GM J Clin Endocrinol Metab; 2000 Dec; 85(12):4683-9. PubMed ID: 11134128 [TBL] [Abstract][Full Text] [Related]
18. Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution. van Hees AM; Saris WH; Dallinga-Thie GM; Hul GB; Martinez JA; Oppert JM; Stich V; Astrup A; Arner P; Sørensen TI; Blaak EE J Nutr; 2008 Dec; 138(12):2399-405. PubMed ID: 19022964 [TBL] [Abstract][Full Text] [Related]
19. The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers. Nakajima K; Nakano T; Moon HD; Nagamine T; Stanhope KL; Havel PJ; Warnick GR Clin Chim Acta; 2009 Jun; 404(2):124-7. PubMed ID: 19345200 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia. Lamendola C; Abbasi F; Chu JW; Hutchinson H; Cain V; Leary E; McLaughlin T; Stein E; Reaven G Am J Cardiol; 2005 Jan; 95(2):189-93. PubMed ID: 15642550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]